Lipoxin A4 stimulates calcium-activated chloride currents and increases airway surface liquid height in normal and cystic fibrosis airway epithelia.
Costello, Richard W
Harvey, Brian J
AffiliationDepartment of Molecular Medicine, RCSI Education and Research Centre, Beaumont Hospital, Dublin, Ireland.
MeSHAnti-Inflammatory Agents, Non-Steroidal
Cystic Fibrosis Transmembrane Conductance Regulator
Dose-Response Relationship, Drug
Primary Cell Culture
Receptors, Formyl Peptide
MetadataShow full item record
CitationLipoxin A4 stimulates calcium-activated chloride currents and increases airway surface liquid height in normal and cystic fibrosis airway epithelia. 2012, 7 (5):e37746 PLoS ONE
AbstractCystic Fibrosis (CF) is a genetic disease characterised by a deficit in epithelial Cl(-) secretion which in the lung leads to airway dehydration and a reduced Airway Surface Liquid (ASL) height. The endogenous lipoxin LXA(4) is a member of the newly identified eicosanoids playing a key role in ending the inflammatory process. Levels of LXA(4) are reported to be decreased in the airways of patients with CF. We have previously shown that in normal human bronchial epithelial cells, LXA(4) produced a rapid and transient increase in intracellular Ca(2+). We have investigated, the effect of LXA(4) on Cl(-) secretion and the functional consequences on ASL generation in bronchial epithelial cells obtained from CF and non-CF patient biopsies and in bronchial epithelial cell lines. We found that LXA(4) stimulated a rapid intracellular Ca(2+) increase in all of the different CF bronchial epithelial cells tested. In non-CF and CF bronchial epithelia, LXA(4) stimulated whole-cell Cl(-) currents which were inhibited by NPPB (calcium-activated Cl(-) channel inhibitor), BAPTA-AM (chelator of intracellular Ca(2+)) but not by CFTRinh-172 (CFTR inhibitor). We found, using confocal imaging, that LXA(4) increased the ASL height in non-CF and in CF airway bronchial epithelia. The LXA(4) effect on ASL height was sensitive to bumetanide, an inhibitor of transepithelial Cl(-) secretion. The LXA(4) stimulation of intracellular Ca(2+), whole-cell Cl(-) currents, conductances and ASL height were inhibited by Boc-2, a specific antagonist of the ALX/FPR2 receptor. Our results provide, for the first time, evidence for a novel role of LXA(4) in the stimulation of intracellular Ca(2+) signalling leading to Ca(2+)-activated Cl(-) secretion and enhanced ASL height in non-CF and CF bronchial epithelia.
- Activation of P2RY11 and ATP release by lipoxin A4 restores the airway surface liquid layer and epithelial repair in cystic fibrosis.
- Authors: Higgins G, Buchanan P, Perriere M, Al-Alawi M, Costello RW, Verriere V, McNally P, Harvey BJ, Urbach V
- Issue date: 2014 Aug
- Lipoxin A₄-mediated KATP potassium channel activation results in cystic fibrosis airway epithelial repair.
- Authors: Buchanan PJ, McNally P, Harvey BJ, Urbach V
- Issue date: 2013 Jul 15
- Lipoxin A4 stimulates a cytosolic Ca2+ increase in human bronchial epithelium.
- Authors: Bonnans C, Mainprice B, Chanez P, Bousquet J, Urbach V
- Issue date: 2003 Mar 28
- Lipoxin A4 prevents tight junction disruption and delays the colonization of cystic fibrosis bronchial epithelial cells by Pseudomonas aeruginosa.
- Authors: Higgins G, Fustero Torre C, Tyrrell J, McNally P, Harvey BJ, Urbach V
- Issue date: 2016 Jun 1
- Effect of duramycin on chloride transport and intracellular calcium concentration in cystic fibrosis and non-cystic fibrosis epithelia.
- Authors: Oliynyk I, Varelogianni G, Roomans GM, Johannesson M
- Issue date: 2010 Dec